Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Expert Review of Dermatology

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/EDM.09.56
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Nutrition support for bone marrow transplant patients.

  2017cited by this paper
• Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complications after allogeneic stem cell transplantation.

  2009cited by this paper
• Thrombotic complications after haematopoietic stem cell transplantation: early and late effects.

  2009cited by this paper
• The burden of bacterial and viral infections in hematopoietic stem cell transplant.

  2009cited by this paper
• Management of infections complicating allogeneic hematopoietic stem cell transplantation.

  2009cited by this paper
• The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation

  2009cited by this paper
• Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children

  2009cited by this paper
• Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.

  2009cited by this paper
• Autologous graft-versus-host disease after denileukin diftitox and autologous stem cell transplantation for refractory T-cell lymphoma

  2009cited by this paper
• Hematopoietic engraftment of dimethyl sulfoxide–depleted autologous peripheral blood progenitor cells

  2009cited by this paper
• Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex.

  2009cited by this paper
• Graft-versus-host disease.

  2009cited by this paper
• Quality of life after allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• How we treat cytomegalovirus in hematopoietic cell transplant recipients.

  2009cited by this paper
• Umbilical cord stem cell transplantation.

  2009cited by this paper
• The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

  2009cited by this paper
• Hematopoietic stem cells and the aging hematopoietic system.

  2008cited by this paper
• Chemotherapeutic agents and the skin: An update.

  2008cited by this paper
• Why are there regional differences in stem cell transplantation activity? An EBMT analysis

  2008cited by this paper
• Syndromes avec vieillissement cutané prématuré : de l’expression phénotypique au gène

  2008cited by this paper
• Novel preparative regimens in hematopoietic stem cell transplantation.

  2008cited by this paper
• Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

  2008cited by this paper
• Vascular endothelium and graft-versus-host disease.

  2008cited by this paper
• Acute skin eruptions that are positive for herpes simplex virus DNA polymerase in patients with stem cell transplantation: a new manifestation within the erythema multiforme reactive dermatoses.

  2008cited by this paper
• Endocrinological late complications after hematopoietic SCT in children

  2008cited by this paper
• Recent progress in allogeneic stem cell transplantation.

  2008cited by this paper
• Ex Vivo Culture of Human Cord Blood Hematopoietic Stem/Progenitor Cells Adversely Influences Their Distribution to Other Bone Marrow Compartments After Intra‐Bone Marrow Transplantation

  2008cited by this paper
• Cutaneous reactions to chemotherapy: commonly seen, less described, little understood.

  2008cited by this paper
• New insights into cord blood stem cell transplantation

  2008cited by this paper
• Leukemia cutis preceding systemic relapse of acute myeloid leukemia

  2008cited by this paper
• Quality of life and social integration after allogeneic hematopoietic SCT

  2008cited by this paper
• Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.

  2008cited by this paper
• Cutaneous toxoplasmosis histologically mimicking graft-versus-host disease.

  2008cited by this paper
• Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance

  2008cited by this paper
• A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.

  2008cited by this paper
• Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies

  2008cited by this paper
• Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation

  2008cited by this paper
• Cutaneous Graft-versus-Host Disease: A Guide for the Dermatologist

  2008cited by this paper
• Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation.

  2008cited by this paper
• Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.

  2008cited by this paper
• Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.

  2008cited by this paper
• Therapy‐related leukaemia cutis: A review

  2008cited by this paper
• Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices.

  2008cited by this paper
• Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.

  2008cited by this paper
• Evolution des conditionnements des greffes allogéniques de cellules souches hématopoïétiques chez l’adulte depuis 10 ans

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Approach to the morbilliform eruption in the hematopoietic transplant patient.

  2007cited by this paper
• Transplantation's greatest challenges: advances in chronic graft-versus-host disease.

  2007cited by this paper
• Long‐term efficacy of topical tacrolimus on oral lesions of chronic graft‐versus‐host disease

  2007cited by this paper
• Neutrophilic dermatoses occurring in oncology patients

  2007cited by this paper
• Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.

  2007cited by this paper
• Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation.

  2007cited by this paper
• Identification of Long‐Term Repopulating Potential of Human Cord Blood‐Derived CD34−flt3− Severe Combined Immunodeficiency‐Repopulating Cells by Intra‐Bone Marrow Injection

  2007cited by this paper
• Second malignancies after allogeneic hematopoietic cell transplantation.

  2007cited by this paper
• Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.

  2007cited by this paper
• Graft-versus-host disease

  2007cited by this paper
• Recognition and management of severe cutaneous drug reactions.

  2007cited by this paper
• Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.

  2007cited by this paper
• The management of posttransplant lymphoproliferative disorder

  2007cited by this paper
• Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product

  2007cited by this paper
• Pathophysiology of acute graft-versus-host disease: recent advances.

  2007cited by this paper
• Allogeneic hematopoietic stem cell transplantation in the elderly.

  2007cited by this paper
• Drug-Induced Skin, Nail and Hair Disorders

  2007cited by this paper
• Oral graft vs. host disease in children – Treatment with topical tacrolimus ointment

  2007cited by this paper
• Immunobiology of allogeneic hematopoietic stem cell transplantation.

  2007cited by this paper
• Photopheresis in pediatric graft‐versus‐host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature

  2007cited by this paper
• The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.

  2006cited by this paper
• Hematopoietic stem-cell transplantation.

  2006cited by this paper
• The clinical spectrum of acute graft-versus-host disease.

  2006cited by this paper
• Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?

  2006cited by this paper
• A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.

  2006cited by this paper
• Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

  2006cited by this paper
• Quality of life associated with acute and chronic graft-versus-host disease

  2006cited by this paper
• The changing face of graft-versus-host disease.

  2006cited by this paper
• Differences between the different conditioning regimens for allogeneic stem cell transplantation

  2006cited by this paper
• Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.

  2006cited by this paper
• Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

  2006cited by this paper
• Diagnosis and treatment of chronic graft-versus-host disease.

  2006cited by this paper
• Transplantation and aging.

  2006cited by this paper
• Cutaneous manifestations of chronic graft-versus-host disease.

  2006cited by this paper
• The prevention of infection post‐transplant: the role of prophylaxis, preemptive and empiric therapy

  2006cited by this paper
• Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation

  2006cited by this paper
• Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

  2005cited by this paper
• Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives

  2005cited by this paper
• Life-threatening graft-vs-host disease.

  2005cited by this paper
• Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus

  2005cited by this paper
• Life-threatening acute adverse cutaneous drug reactions.

  2005cited by this paper
• Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin

  2005cited by this paper
• Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.

  2005cited by this paper
• Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow

  2004cited by this paper
• Mucocutaneous side effects of antineoplastic chemotherapy

  2004cited by this paper
• Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.

  2004cited by this paper
• Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation

  2003cited by this paper
• Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria

  2003cited by this paper
• Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease

  2003cited by this paper
• Clinical and Laboratory Investigations Analysis of risk factors for acute cutaneous graft-versus-host disease after allogeneic stem cell transplantation

  2003cited by this paper
• Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

  2003cited by this paper
• The International Bone Marrow Transplant Registry

  2002cited by this paper
• Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.

  2002cited by this paper
• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

  2002cited by this paper

• Long-Term Follow-Up and Chronic Complications

  2020cites this paper
• Study of the Incidence of Muco-cutaneous Graft Versus Host Disease among patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation in an Indian setting

  2011influential citation